Edgewise Therapeutics, Inc. (EWTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -42.54M | -38.59M | -34.78M | -32.58M | -37.87M | -26.96M | -27.37M | -26.1M | -28.6M | -26.83M | -22.06M | -20.23M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -12.35% | -43.16% | -27.04% | -24.84% | -32.41% | -0.47% | -24.1% | -28.99% | -25.29% | -126.99% | -83.85% | -24.56% |
| Net Income | -49.01M | 117.58M | -40.67M | -36.12M | -40.8M | -39.66M | -34.13M | -31.5M | -28.52M | -30.14M | -25.71M | -21.47M |
| Depreciation & Amortization | 590K | -1.69M | 570K | 567K | 554K | 629K | 602K | 534K | 525K | 533K | 497K | 437K |
| Stock-Based Compensation | 0 | -24.88M | 8.09M | 7.73M | 9.06M | 7.74M | 6.88M | 5.22M | 4.87M | 5.15M | 4.56M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.3M | 2.18M | 0 |
| Other Non-Cash Items | 7.7M | -132.26M | -4.19M | -2.2M | -1.92M | -2.6M | -3.24M | -3.55M | -3.15M | 1.13M | -4.56M | 1.14M |
| Working Capital Changes | -1.82M | 2.66M | 1.42M | -2.56M | -4.76M | 6.94M | 2.51M | 3.19M | -2.32M | -201K | 974K | -342K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.45M | -303K | 0 | -151K | 2.86M | 92K | -1.03M | 1.89M | 780K | -1.38M | 1.76M | -312K |
| Cash from Investing | 2.43M | 49.76M | 35.72M | -162.17M | 43.9M | 20.92M | 25.36M | 37.37M | -268.31M | 26.98M | 23.42M | 3.44M |
| Capital Expenditures | -260K | 183K | -89K | -50K | -44K | -274K | -520K | -221K | -297K | -161K | -457K | -759K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -27.14K | -23.88K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -32.79M | 35.8M | 0 | 0 | 0 | 0 | 0 | 0 | 27.14K | 23.88K | 0 |
| Cash from Financing | 12.17M | 3.98M | 1.66M | 188.23M | 2.22M | 2.9M | 3.33M | 1.95M | 241.07M | 52.99M | -211K | 369K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 12.17M | 4.57M | 0 | 187.36M | 2.22M | 3.16M | 3.29M | 2M | 239.15M | 52.62M | -211K | 369K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -598K | 1.66M | 869K | 0 | -262K | 48K | -48K | 1.93M | 369K | 0 | 0 |
| Net Change in Cash | -27.94M | 15.14M | 2.6M | -6.52M | 8.26M | -3.14M | 1.32M | 13.22M | -55.83M | 53.14M | 1.15M | -16.42M |
| Free Cash Flow | -42.8M | -38.41M | -34.87M | -32.63M | -37.91M | -27.23M | -27.89M | -26.32M | -28.89M | -26.99M | -22.52M | -20.99M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -12.91% | -41.05% | -24.99% | -23.98% | -31.2% | -0.89% | -23.89% | -25.38% | -6.26% | -78.59% | -68.93% | -24.97% |
| FCF per Share | -0.40 | -0.37 | -0.33 | -0.31 | -0.40 | -0.29 | -0.30 | -0.28 | -0.33 | -0.42 | -0.35 | -0.33 |
| FCF Conversion (FCF/Net Income) | 0.87x | 0.77x | 0.86x | 0.90x | 0.93x | 0.68x | 0.80x | 0.83x | 1.00x | 0.89x | 0.86x | 0.94x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |